Sort
27,075 grants matching “cholesterol”
MOLECULAR DETERMINANTS OF THE STABILITY OF ATHEROMA
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
DETECTION AND MODULATION OF THE VULNERABLE ATHEROSCLEROTIC PLAQUE
$368,363Brigham And Women'S Hospital · P50 · FY2000 · HL
Mechanisms regulating lipoprotein secretion and lipid metabolism
$368,337Hongmin Ni · University Of Kansas Medical Center · R01 · FY2025 · DK
Weight loss in the treatment of type 2 diabetes
$368,331William C Knowler · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Genetic Epidemiology of Diabetic Complications
$368,331William C Knowler · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
CYP17A1-independent androgen synthesis and prostate cancer resistance to next-generation hormonal therapy
$368,288Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
HIV protease inhibitors, marcophage function/estrogen
$368,250University Of Kentucky · R01 · FY2003 · HL
HIV protease inhibitors, marcophage function/estrogen
$368,250University Of Kentucky · R01 · FY2005 · HL
HIV protease inhibitors, marcophage function/estrogen
$368,250University Of Kentucky · R01 · FY2004 · HL
FAK regulation of cholesterol influx and efflux in foam cells
$368,232Steve Lim · University Of Alabama At Birmingham · R01 · FY2024 · HL
Modeling synaptic vesicles: how does alpha-Synuclein inhibit fusion?
$368,223Jonathan N Sachs · University Of Minnesota · R01 · FY2015 · NS
Regulation of Lysosomes in Autophagy in Coronary Arterial Myocytes
$368,143Pin-Lan Li · Virginia Commonwealth University · R01 · FY2015 · HL
Identification and Treatment Of Unstable Plaque with OCT
$368,140Mark E Brezinski · Brigham And Women'S Hospital · R01 · FY2008 · EB
Macrophage-specific targeting of LXRs in CVD and NASH
$368,128Christopher K Glass · University Of California, San Diego · P01 · FY2022 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$368,126Joseph L Witztum · University Of California, San Diego · P01 · FY2022 · HL
Group V sPLA2 in Atherosclerosis
$368,063University Of Kentucky · R01 · FY2004 · HL
Creating Engineered Models of Valvular Disease to Study Anti-Calcific Therapies
$368,060Kristyn S Masters · University Of Wisconsin-Madison · R01 · FY2011 · HL
Social-biological predictors of heterogeneity in CVD risk in African Americans
$368,019Ana V Diez Roux · University Of Michigan At Ann Arbor · P60 · FY2016 · MD
HCV in Alcoholics
$367,988Jack R Wands · Rhode Island Hospital · R01 · FY2010 · AA
TMAO, the Gut Microbiome, and Colorectal Cancer Risk in the Multiethnic Cohort
$367,984Unhee Lim · University Of Hawaii At Manoa · R01 · FY2016 · CA
Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old
$367,967Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AG
Membrane Control of Protein-Protein Contact. Simulation Based on Phase Diagrams
$367,960Gerald William Feigenson · Cornell University · R01 · FY2010 · GM
HIV Associated CNS Dysfunction with Aging
$367,875Johns Hopkins University · R01 · FY2005 · AG
From Sugar to Fat: How the Transcription Factor XBP1 Regulates Hepatic Lipogenesi
$367,875Laurie H Glimcher · Harvard School Of Public Health · R01 · FY2010 · DK
EFFECTS OF VULNERABILITY AND RESILIENCY ON BRAIN HEALTH DURING THE MID-TO-LATE-LIFE TRANSITION
$367,875Helen Lavretsky · Washington University · U19 · FY2023 · AG